AIM/HCM (AIM/HCM)

London Stock Exchange AIM: AIM/HCM · GBX

GBX 210

+1.60 (+0.8%)· Recorded snapshot

Market cap	1.8B
Revenue (ttm)	413.9M
Net income (ttm)	13.5M
EPS (ttm)	GBX 0.02
Shares out	869.1M
P/E (trailing)	137.7x
P/E (forward)	42.5x
Volume	7,838
Beta	0.36

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 413.9M
Net income (ttm): 13.5M
EPS (ttm): GBX 0.02
P/E (trailing): 137.7x
P/E (forward): 42.5x
Market cap: 1.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E42.5

P25 13.4P50 18.5P75 26.8

Trailing P/E137.7

P25 16.1P50 24.2P75 39.8

ROE1.5

P25 -48.7P50 3.8P75 15.3

ROIC-1,741.7

P25 -35.4P50 4.3P75 12.3

Benchmarks · 1M

All AIM/HCM indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

USD

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	GBP
Country	Cayman Islands
Country code	UK
Earnings date	2026-11-13
Employees	1,790
Enterprise value	GBX 866.1M
Exchange	London Stock Exchange AIM
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2000
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	KYG4672N1198
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split date	2019-05-30
Last stock split type	Forward
Market cap	GBX 1.8B
Next earnings date	2026-11-13
Price	GBX 209.60
Price currency	GBX
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	aim/HCM
Website	https://www.hutch-med.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	41.7x
Earnings yield	0.73%
EV/Earnings	63.22x
EV/FCF	113.64x
EV/Sales	2.06x
FCF / EV yield	0.88%
FCF yield	0.41%
Forward P/E	42.47x
Graham number	61.185
Graham upside	-70.81%
Industry forward P/E	16.62x
Industry P/E	20.6x
P/(OCF - SBC) ratio	253.82x
P/B ratio	1.88x
P/E ratio	137.74x
P/FCF ratio	241.07x
P/OCF ratio	117.22x
P/S ratio	4.37x
Price / tangible book value	1.9x
Sector forward P/E	14.49x
Sector P/E	22.58x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-6.33%
EBITDA margin	-3.74%
Effective tax rate	8.25%
FCF margin	1.82%
Gross margin	13.31%
Operating margin	-6.33%
Pretax margin	3.66%
Profit margin	3.26%
Profit per employee	GBX 7,530
Profitable years	3
Revenue per employee	GBX 231,214
ROA	-1.24%
ROA (5Y)	-8.71%
ROCE	-2.38%
ROE	1.46%
ROE (5Y)	0.1%
ROIC	-1,741.75%
SBC / revenue	2.01%
Tax / revenue	0.3%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-96.19%
EPS growth (Q)	-96.46%
EPS growth (QoQ)	9,382.99%
EPS growth quarters	2
EPS growth years	1
FCF growth (QoQ)	96.45%
FCF growth 3Y	60.77%
Gross profit growth (Q)	24.24%
Gross profit growth 3Y	-24.52%
Net income growth	-96.17%
Net income growth (Q)	-96.5%
Net income growth (QoQ)	714.73%
Net income growth quarters	2
Net income growth years	1
OCF growth (QoQ)	48.39%
OCF growth 3Y	-24.56%
Revenue growth	-8.81%
Revenue growth (Q)	0.22%
Revenue growth (QoQ)	2.75%
Revenue growth 10Y	10.61%
Revenue growth 3Y	-10.16%
Revenue growth 5Y	14.54%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	GBX -7.9M
Depreciation and amortization	GBX 10.7M
EBIT	GBX -26.2M
EBITDA	GBX -15.5M
EPS	GBX 0.02
FCF per share	GBX 0.01
Financing cash flow	GBX -3.3M
Free cash flow	GBX 7.5M
Free cash flow minus SBC	GBX -800,430
Gross profit	GBX 55.1M
Income taxes	GBX 1.2M
Investing cash flow	GBX -18.8M
Net borrowing	GBX -3.6M
Net cash flow	GBX -3.1M
Net income	GBX 13.5M
Operating cash flow minus SBC	GBX 7.1M
Operating income	GBX -26.2M
Revenue	GBX 413.9M
Stock-based compensation	GBX 8.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	4.08
Book value per share	GBX 1.09
Debt / equity	0.07
Debt / FCF	9.5
Interest coverage	-12.14
Long-term assets	GBX 142.2M
Long-term liabilities	GBX 141.1M
Net cash (debt)	GBX 966.2M
Net cash / market cap	53.45%
Net cash growth	1.35%
Net debt / equity	-1.01
Net debt / FCF	-128.85
Piotroski F-Score	5
Property, plant and equipment	GBX 70.4M
Shareholders' equity	GBX 960.9M
Tangible book value	GBX 950.2M
Tangible book value per share	GBX 1.09
Total assets	GBX 1.3B
Total cash	GBX 1B
Total debt	GBX 71.2M
Total liabilities	GBX 347.8M
WACC	6.11%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.31
Current assets	GBX 1.2B
Current liabilities	GBX 206.7M
Current ratio	5.64
Inventory turnover	10.66
Net working capital	GBX -57.2M
Quick ratio	5.45
Working capital	GBX 963.4M
Working capital turnover	0.33

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.02%
Shareholder yield	-0.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	12.69%
10Y return CAGR	1.2%
10Y total return	12.69%
150-day SMA	GBX 190.90
15Y price change	622.76%
15Y return CAGR	14.09%
15Y total return	622.76%
1D price change	0.77%
1M price change	-2.96%
1M total return	-2.96%
1W price change	-5.59%
1W total return	-5.59%
1Y price change	-5.16%
1Y return CAGR	-5.16%
1Y total return	-5.16%
20-day SMA	GBX 214.65
200-day SMA	GBX 197.13
20Y price change	1,292.69%
20Y return CAGR	14.08%
20Y total return	1,292.69%
3M price change	24.02%
3M total return	24.02%
3Y price change	-30.83%
3Y return CAGR	-11.56%
3Y total return	-30.83%
50-day SMA	GBX 205.26
50-day SMA vs 200-day SMA	50over200
52-week high	GBX 239.00
52-week high date	2026-01-21
52-week low	GBX 150.50
52-week low date	2026-06-22
5Y price change	-53.83%
5Y return CAGR	-14.32%
5Y total return	-53.83%
6M price change	5.59%
6M total return	5.59%
All-time high	GBX 656.00
All-time high date	2021-06-30
All-time low	GBX 3.50
All-time low date	2008-12-17
Average true range (ATR)	GBX 10.49
Average volume	21.3K
Beta (1Y)	0.92
Beta (2Y)	0.7
Beta (5Y)	0.36
Change from 52-week high	-12.3%
Change from 52-week low	39.27%
Change from all-time high	-68.05%
Change from all-time low	5,888.57%
Change from open	-3.85%
Day's gap	4.81%
Dollar volume	GBX 1.6M
High price	GBX 218.00
Low price	GBX 201.00
Monthly RSI	47.29
Open price	GBX 218.00
Position in 52-week range	50.59%
Previous close	GBX 208.00
Price vs 150-day SMA	9.8%
Price vs 20-day SMA	-2.35%
Price vs 200-day SMA	6.32%
Price vs 50-day SMA	2.11%
Relative volume	0.37
RSI	44.94
Sharpe ratio	-0.02
Sharpe ratio (3Y)	-0.1
Sharpe ratio (5Y)	0.01
Sortino ratio	0.12
Sortino ratio (3Y)	-0.03
Sortino ratio (5Y)	0.11
Volume	7.8K
Weekly RSI	53.3
YTD price change	0.77%
YTD total return	0.77%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	528.1M
Shares change (QoQ)	-0.04%
Shares change (YoY)	0.02%
Shares held by insiders	0.97%
Shares held by institutions	19.52%
Shares outstanding	869.1M

Deeper analysis on AIM/HCM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this AIM/HCM report

Is a complete AIM/HCM research report available?

No complete published report is available for aim/HCM (AIM/HCM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/HCM (AIM/HCM)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/HCM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/HCM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on AIM/HCM

Frequently asked questions